Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a prospective study that will explore the mechanisms of efficacy of dimethyl fumarate (DMF) treatment in multiple sclerosis (MS). Investigators will enroll relapsing MS patients who are beginning therapy with DMF into a one-year longitudinal study in which blood and spinal fluid analyses, imaging and clinical studies will be performed to identify and measure changes associated with DMF therapy.
Epistemonikos ID: 5e1680d82485eb88bb02b9c0ee211b38388678c2
First added on: May 12, 2024